Cocrystal Pharma Inc (COCP) Annual Balance Sheets

Annual · GAAP · USD millions
Access COCP quarterly Balance Sheets →
Looking at balance sheet data from Cocrystal Pharma Inc through Dec 31 2021 provides insight into Dec 31 2025's solvency and capital structure over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent7.03
Restricted Cash and Cash Equivalents, Current0.00
Cash & Short-term Investments7.00
Value Added Tax Receivable, Current0.71
Other Current Assets0.07
Prepaid Expense And Other Assets Current0.33
Total Current Assets8.13
Equipment/Property/Plant Net0.09
Goodwill net0.00
Deposits Assets, Noncurrent AS0.10
Other Assets, Noncurrent0.00
Restricted Cash Current0.08
Operating Lease Right Of Use Asset1.39
Total Assets9.71
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.88
Derivative Liability, Current DE0.00
Other Liabilities, Current0.00
Total Current Liabilities2.21
Total Long-term Debt0.00
Finance Lease Liability Current-
Operating Lease Liability Current0.33
Finance Lease Liability Noncurrent-
Operating Lease Liability Noncurrent1.17
Total Liabilities3.38
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock348.57
Retained Earnings / Accumulated Deficit-342.25
Other Equity0.00
Common Stockholder's Equity6.33
Total Stockholder's Equity6.33
Liabilities & Stockholder's Equity9.71
4 historic quarters locked

Sign in to unlock the full Cocrystal Pharma Inc balance sheet history.

About Cocrystal Pharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-013838

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.